# AtheroGenics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atherogenics

- Industry: Pharmaceuticals
- Headquarters: Alpharetta, US
- Website: www.atherogenics.com
- Total disclosed funding: $22M
- Latest round: Series C (Sep 15, 1999)
- Investors on record: 6

## About

AtheroGenics, Inc. engages in discovery and development of drugs for inflammatory diseases.

## Funding rounds

- Series C, Sep 15, 1999, $8M — William Blair Capital Partners
- Series C, Jul 31, 1996, $9.3M — Domain Associates, Sprout Group
- Series B, Jan 4, 1996, $5.1M — Sanderling Ventures, Alliance Technology Ventures, Apogem Capital
- Series A, Jun 1, 1994 — Alliance Technology Ventures

## Investors

- Alliance Technology Ventures (https://capitalatlas.ai/funds/alliance-technology-ventures) — Series A, Series B
- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series B
- Apogem Capital (https://capitalatlas.ai/funds/apogem-capital) — Series B
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series C
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series C
- William Blair Capital Partners (https://capitalatlas.ai/funds/william-blair-capital-partners) — Series C